Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies
HIT Consultant
SEPTEMBER 20, 2022
What You Should Know: – Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M Finally, mitochondrial quality control will be targeted using small molecules that modulate mitochondria’s built-in quality control system.
52 
Let's personalize your content